BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 11977455)

  • 1. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
    Wigand R
    Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
    [No Abstract]   [Full Text] [Related]  

  • 2. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 3. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 4. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 5. [COX-2 inhibitor to whom?].
    Martio J
    Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
    [No Abstract]   [Full Text] [Related]  

  • 6. NSAIDs to prevent colorectal cancer: a question of sensitivity.
    Elder DJ; Paraskeva C
    Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
    Yamamoto DS; Viale PH
    Clin J Oncol Nurs; 2003; 7(1):21-9. PubMed ID: 12629931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
    Pascucci RA
    J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 11. Wolf in sheep's clothing?
    Varga J
    Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current post-marketing information. Effects and adverse effects of celecoxib].
    Schmidt H; Geisslinger G
    Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
    [No Abstract]   [Full Text] [Related]  

  • 13. COX-2 inhibition for postoperative analgesia.
    McCrory C; E Lindahl SG
    Anesth Analg; 2003 Apr; 96(4):1235. PubMed ID: 12651698
    [No Abstract]   [Full Text] [Related]  

  • 14. Getting a grip on pain. A new drug may revolutionize arthritis care.
    Cowley G
    Newsweek; 1998 Dec; 132(24):66. PubMed ID: 10338868
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 16. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.